#2 - Clover Health Investments (NASDAQ:CLOV)
Clover Health Investments (NASDAQ: CLOV) is one of many companies trying to crack the code of making Medicare and Medicaid profitable. Clover focuses on Medicare Advantage, which is different from traditional Medicare in that it allows subscribers to get health and prescription drug coverage through plans offered by private insurers.
Not surprisingly, AI is at the center of the bullish proposition for CLOV stock. Through its Clover Assistant, the company is using AI as a tool for “empowering physicians with data-driven, personalized insights at the point of care.”
A recent study conducted by USC Schaeffer highlights the fact that demand for Medicare Advantage plans is increasing. This growth is in line with the Aging of America. And for its part, Clover says it pays physicians a premium over the traditional Medicare rate for office visits when the provider uses the Clover Assistant.
If these trends continue, it could propel Clover Health to profitability, something that has remained elusive. And also a fact that is weighing on the company’s stock.
About Clover Health Investments
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
More- Current Price
- $4.47
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 1 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $5.00 (11.9% Upside)
